Levodopa/Carbidopa (4:1)

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
201	アンジェルマン症候群	1

201. アンジェルマン症候群

臨床試験数 : 25 / 薬物数 : 40 - (DrugBank : 11) / 標的遺伝子数 : 22 - 標的パスウェイ数 : 20

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00829439 (ClinicalTrials.gov)	January 2009	26/1/2009	Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome	A Dose-escalation Tolerability Study of Levodopa/Carbidopa in Angelman Syndrome	Angelman Syndrome	Drug: Levodopa/Carbidopa (4:1)	Boston Children’s Hospital	NULL	Completed	4 Years	12 Years	All	16	Phase 1	United States